RDF/XML JSON-LD N3/Turtle RDF/JSON

Soria Chacartegui, Paula paula.soria@uam.es

Farmacología / Universidad Autónoma de Madrid

Publications

Association between CYP2C19 and CYP2B6 phenotypes and the pharmacokinetics and safety of diazepam

  • Zubiaur P
  • Figueiredo-Tor L
  • Villapalos-García G
  • Soria-Chacartegui P
  • Navares-Gómez M
  • Novalbos J
  • Matas M
  • Calleja S
  • Mejía-Abril G
  • Román M
  • Ochoa D
  • Abad-Santos F
... View more Collapse

Biomedicine & Pharmacotherapy - 1/11/2022

10.1016/j.biopha.2022.113747 View at source

  • ISSN 07533322

CYP2C83 and 4 define CYP2C8 phenotype: An approach with the substrate cinitapride

  • Campodonico, Diana Maria
  • Zubiaur, Pablo
  • Soria-Chacartegui, Paula
  • Casajus, Ana
  • Villapalos-Garcia, Gonzalo
  • Navares-Gomez, Marcos
  • Gomez-Fernandez, Antia
  • Parra-Garces, Raul
  • Mejia-Abril, Gina
  • Roman, Manuel
  • Martin-Vilchez, Samuel
  • Ochoa, Dolores
  • Abad-Santos, Francisco;
... View more Collapse

Cts-Clinical And Translational Science (p. 2613-2624) - 1/11/2022

10.1111/cts.13386 View at source

  • ISSN 17528054

Clinical relevance of novel polymorphisms in the dihydropyrimidine dehydrogenase (Dpyd) gene in patients with severe fluoropyrimidine toxicity: A spanish case-control study

  • Soria-Chacartegui P
  • Villapalos-García G
  • López-Fernández LA
  • Navares-Gómez M
  • Mejía-Abril G
  • Abad-Santos F
  • Zubiaur P
... View more Collapse

Pharmaceutics - 1/12/2021

10.3390/pharmaceutics13122036 View at source

  • ISSN 19994923

Effect of Sex, Use of Pantoprazole and Polymorphisms in SLC22A1, ABCB1, CES1, CYP3A5 and CYP2D6 on the Pharmacokinetics and Safety of Dabigatran

  • Zubiaur P
  • Saiz-Rodríguez M
  • Ochoa D
  • Navares-Gómez M
  • Mejía G
  • Román M
  • Koller D
  • Soria-Chacartegui P
  • Almenara S
  • Abad-Santos F
... View more Collapse

Advances In Therapy (p. 3537-3550) - 1/8/2020

10.1007/s12325-020-01414-x View at source

  • ISSN 0741238X

Genetic Polymorphisms Associated With the Pharmacokinetics, Pharmacodynamics and Adverse Effects of Olanzapine, Aripiprazole and Risperidone

  • Soria-Chacartegui, Paula
  • Villapalos-Garcia, Gonzalo
  • Zubiaur, Pablo
  • Abad-Santos, Francisco
  • Koller, Dora;

Frontiers In Pharmacology - 14/7/2021

10.3389/fphar.2021.711940 View at source

  • ISSN 16639812

Genetic Variation in CYP2D6 and SLC22A1 Affects Amlodipine Pharmacokinetics and Safety

  • Soria-Chacartegui P
  • Zubiaur P
  • Ochoa D
  • Villapalos-García G
  • Román M
  • Matas M
  • Figueiredo-Tor L
  • Mejía-Abril G
  • Calleja S
  • de Miguel A
  • Navares-Gómez M
  • Martín-Vilchez S
  • Abad-Santos F
... View more Collapse

Pharmaceutics - 1/2/2023

10.3390/pharmaceutics15020404 View at source

  • ISSN 19994923

Genotype-Guided Prescription of Azathioprine Reduces the Incidence of Adverse Drug Reactions in TPMT Intermediate Metabolizers to a Similar Incidence as Normal Metabolizers

  • Casajús A
  • Zubiaur P
  • Méndez M
  • Campodónico D
  • Gómez A
  • Navares-Gómez M
  • Villapalos-García G
  • Soria-Chacartegui P
  • Novalbos J
  • Román M
  • Mejía-Abril G
  • Ochoa D
  • Abad-Santos F
... View more Collapse

Advances In Therapy (p. 1743-1753) - 1/4/2022

10.1007/s12325-022-02067-8 View at source

  • ISSN 0741238X

Impact of polymorphisms in CYP and UGT enzymes and ABC and SLCO1B1 transporters on the pharmacokinetics and safety of desvenlafaxine

  • Calleja S
  • Zubiaur P
  • Ochoa D
  • Villapalos-García G
  • Mejia-Abril G
  • Soria-Chacartegui P
  • Navares-Gómez M
  • de Miguel A
  • Román M
  • Martín-Vílchez S
  • Abad-Santos F
... View more Collapse

Frontiers In Pharmacology - 2/2/2023

10.3389/fphar.2023.1110460 View at source

  • ISSN 16639812

Impact of polymorphisms in transporter and metabolizing enzyme genes on olanzapine pharmacokinetics and safety in healthy volunteers

  • Zubiaur P
  • Soria-Chacartegui P
  • Koller D
  • Navares-Gómez M
  • Ochoa D
  • Almenara S
  • Saiz-Rodríguez M
  • Mejía-Abril G
  • Villapalos-García G
  • Román M
  • Martín-Vílchez S
  • Abad-Santos F
... View more Collapse

Biomedicine & Pharmacotherapy - 1/1/2021

10.1016/j.biopha.2020.111087 View at source

  • ISSN 07533322

NAT2 phenotype alters pharmacokinetics of rivaroxaban in healthy volunteers

  • Villapalos-García G, Zubiaur P, Ochoa D, Soria-Chacartegui P, Navares-Gómez M, Matas M, Mejía-Abril G, Casajús-Rey A, Campodónico D, Román M, Martín-Vílchez S, Candau-Ramos C, Aldama-Martín M, Abad-Santos F

Biomedicine & Pharmacotherapy (p. 115058-115058) - 1/1/2023

10.1016/j.biopha.2023.115058

  • ISSN 07533322
  • iMarina

This researcher has no books.

This researcher has no book chapters.

This researcher has no conferences.

This researcher has no working papers.

This researcher has no technical reports.

This researcher has no research projects.

This researcher has no supervised thesis.

This researcher has no patents or software licenses.

Last data update: 3/18/24 3:09 PM